Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Menopausal Hormone Therapy for Women With Schizophrenia: What's Stopping Us?

Reilly TJ. and McCutcheon RA., (2024), Am J Psychiatry, 181, 854 - 855

Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.

Livingston NR. et al, (2024), Neuropsychopharmacology, 49, 1448 - 1458

The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis.

Reilly TJ. et al, (2024), J Affect Disord

Point of care assay for blood aripiprazole concentrations: development, validation and utility.

Atkins M. et al, (2023), Br J Psychiatry, 223, 389 - 393

A case series of premenstrual disorders presenting to the UK's National Female Hormone Clinic

Reilly T., (2023), BJPsych Bulletin

Systematic review of the association between adverse life events and the onset and relapse of postpartum psychosis

Reilly T. et al, (2023), Frontiers in Psychiatry

Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials

Reilly TJ. et al, (2023), Journal of Psychopharmacology, 37, 261 - 267

Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022).

Reilly TJ., (2023), Eur J Neurosci, 57, 456 - 457

Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis.

Reilly TJ. et al, (2020), Schizophr Bull, 46, 78 - 90

E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry.

Reilly T. et al, (2019), JMIR Ment Health, 6

IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE

Fusar-poli P. et al, (2018), SCHIZOPHRENIA BULLETIN, 44, S56 - S57

Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.

Fusar-Poli P. et al, (2017), JAMA Psychiatry, 74, 493 - 500

Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?

Stone J. et al, (2017), Psychol Med, 47

The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.

Stone JM. et al, (2016), Psychol Med, 46, 3443 - 3450

Include forthcoming?